Sort
15,842 grants matching “pancreatic cancer”
Chemoprevention by a Targeted Thioredoxin Inhibitor.
$319,550Garth Powis · University Of Tx Md Anderson Can Ctr · R01 · FY2010 · CA
Pancreatic Ductal Adenocarcinoma is a disease of constitutive autophagy
$319,550Herbert J Zeh · University Of Pittsburgh At Pittsburgh · R01 · FY2017 · CA
FUNCTIONAL GENOMIC IDENTIFICATION AND CHARACTERIZATION OF THERAPEUTIC TARGETS
$319,526Ronald Anthony Depinho · Dana-Farber Cancer Inst · P01 · FY2011 · CA
Ribonucleases in Cancer Chemotherapy
$319,495Ronald T Raines · University Of Wisconsin-Madison · R01 · FY2009 · CA
Ribonucleases in Cancer Chemotherapy
$319,495Ronald T Raines · University Of Wisconsin-Madison · R01 · FY2010 · CA
Mechanism by which the Grp94 molecular chaperone folds insulin-like growth factors
$319,395Timothy Oliver Street · Brandeis University · R01 · FY2018 · GM
Mechanism by which the Grp94 molecular chaperone folds insulin-like growth factors
$319,395Timothy Oliver Street · Brandeis University · R01 · FY2019 · GM
Mechanism by which the Grp94 molecular chaperone folds insulin-like growth factors
$319,395Timothy Oliver Street · Brandeis University · R01 · FY2017 · GM
CCR2 BLOCKADE IN HUMAN PANCREATIC CANCER
$319,377David C Linehan · University Of Rochester · R01 · FY2017 · CA
Neuropeptide Regulation of Enteropancreatic Function
$319,376Michael W. Mulholland · University Of Michigan At Ann Arbor · R37 · FY2008 · DK
Treatment of Hypoxia Resistance in Pancreatic Cancer -Lab
$319,364Garth Powis · Translational Genomics Research Inst · P01 · FY2009 · CA
Color-Coded Imaging of Pancreatic Cancer Microenvironment for Drug Discovery
$319,169Michael Bouvet · University Of California, San Diego · R01 · FY2009 · CA
Fluorophore-Conjugated Antibodies for Imaging and Resection of GI Tumors
$319,169Michael Bouvet · University Of California, San Diego · R01 · FY2010 · CA
Mutant mouse models of exocrine pancreatic cancer
$319,121University Of Pennsylvania · R01 · FY2004 · CA
Novel Theranostics for Pancreatic Cancer
$319,031Julia Davydova · University Of Minnesota · R01 · FY2018 · CA
Novel Theranostics for Pancreatic Cancer
$319,031Julia Davydova · University Of Minnesota · R01 · FY2016 · CA
Novel Theranostics for Pancreatic Cancer
$319,031Julia Davydova · University Of Minnesota · R01 · FY2017 · CA
Novel Theranostics for Pancreatic Cancer
$319,031Julia Davydova · University Of Minnesota · R01 · FY2015 · CA
Project 3: The Functional Contribution of Tumor Immunity in PDAC
$319,026Raghu Kalluri · University Of Tx Md Anderson Can Ctr · P01 · FY2020 · CA
Bispecific Antibody Pretargeted Therapy of Pancreatic Cancer
$319,025Robert M Sharkey · Ctr For Molecular Medicine/Immunology · R01 · FY2007 · CA
Bispecific Antibody Pretargeted Therapy of Pancreatic Cancer
$319,025Robert M Sharkey · Ctr For Molecular Medicine/Immunology · R01 · FY2008 · CA
DIABETES AND ENDOCRINOLOGY RESEARCH CENTER
$318,919Joslin Diabetes Center · P30 · FY2001 · DK
Dissecting Hedgehog, TGF beta and BMP Signaling During Pancreatic Tumorigenesis
$318,713Brian C Lewis · Univ Of Massachusetts Med Sch Worcester · R01 · FY2013 · CA
Molecular Markers for the Diagnosis of Pancreatic Cancer
$318,643Surinder Kumar Batra · University Of Nebraska Medical Center · R01 · FY2008 · CA
Targeting Akt/NF-kappa beta for Pancreatic Cancer Therapy
$318,565Fazlul H. Sarkar · Wayne State University · R01 · FY2007 · CA